Symbols

NUS

Nu Skin Enterprises·NYSE

--(--)

7.99 / 10

Outperform

Analyst coverage is absent, though Portolan Capital recently bought 596k shares, signaling institutional interest. Fund‑flow score is 7.99 (good); overall and block inflows are positive, extra‑large investors are net buyers, while small‑to‑large segments show slight outflows.

Fund Flow Rating

Is money flowing into or out of NUS?

NUS holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.99/10 (Outperform).